Showing results (771-780 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|September 13, 2024
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsCharles S Haworth, Michal Shteinberg, Kevin Winthrop, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trialBaohui Han, Trevor Feinstein, Yuankai Shi, et al.
The Lancet. Respiratory Medicine|December 2, 2024
Idiopathic inflammatory myopathies related lung disease in adultsSameep Sehgal, Aditi Patel, Soumya Chatterjee, et al.
The Lancet. Respiratory Medicine|November 24, 2024
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trialDongsheng Yue, Wenxiang Wang, Hongxu Liu, et al.
The Lancet. Respiratory Medicine|June 19, 2023
Cough and cough hypersensitivity as treatable traits of asthmaKefang Lai, Imran Satia, Woo-Jung Song, et al.
The Lancet. Respiratory Medicine|March 25, 2026
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trialStacy Todd, Joanne Euden, Jennifer Condie, et al.
The Lancet. Respiratory Medicine|March 27, 2026
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaborationAnne-Marie C Dingemans, Isabelle Opitz, Alessandro Brunelli, et al.
The Lancet. Respiratory Medicine|March 19, 2026
Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trialErik H A Michels, Pierre-François Dequin, Joe M Butler, et al.
The Lancet. Respiratory Medicine|April 25, 2026
Non-invasive respiratory supports and criteria for intubation in randomised trials of acute hypoxaemic respiratory failure: a systematic review and network meta-analysisKevin G Lee, Madeline Hopkins, Rachel Couban, et al.
The Lancet. Respiratory Medicine|July 13, 2026
The role of sweat chloride in determining CFTR protein restoration in people with cystic fibrosisEdith T Zemanick, Simon Y Graeber, Carlo Castellani, et al.
Pageof 104